In this Q&A, the primary study author shares key findings and how providers can use them to improve patient care now.
Author: Megan Davis (Page 3)
Our expanded partnership with Riverside Health improves access to liver transplants in eastern Virginia. Our blood cancer and stem cell transplant experts are now seeing patients in Northern Virginia. Plus, we're the first in the U.S. to offer a newly FDA-approved vascular conduit for critical vessel repair.
This B cell therapy is a subcutaneous injection that can be administered in minutes instead of hours, offering a significant quality of life boost to patients.
In this Q&A, neuro-oncologist Camilo Fadul, MD, shares how brain metastases care is changing and what every clinician should know about treating it.
UVA Health’s multidisciplinary breast cancer care team brings together experts from across the care continuum to effectively and compassionately treat patients with all types of breast cancer.
We're accepting referrals for both bronchiectasis and nontuberculous mycobacterial (NTM) lung disease hernia care.
Our multidisciplinary program offers specialized treatments, innovative clinical trials, and genetic counseling.
UVA Health's Pituitary Tumor Program ensures optimal patient outcomes through collaboration, cutting-edge techniques, and streamlined care pathways.
We're accepting referrals for TCAR for CAD and aquablation for BPH. We've also opened a new adult wheelchair care clinic.
Kirsten Greene, MD, shares need-to-know details about PSA testing, active surveillance, and more in this Q&A.